Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer Jul 10, 2023 | Uncategorized
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition Jul 10, 2023 | Uncategorized
In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells Nov 5, 2018 | HIV
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors Nov 5, 2018 | Uncategorized
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial Apr 5, 2018 | Uncategorized
